Cromwell Holdings’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.62K Buy
67
+31
+86% +$1.15K ﹤0.01% 794
2026
Q1
$1.44K Sell
36
-2
-5% -$95 ﹤0.01% 773
2025
Q4
$1.71K Sell
38
-1,110
-97% -$51.3K ﹤0.01% 717
2025
Q3
$51.3K Hold
1,148
0.03% 476
2025
Q2
$55.2K Buy
1,148
+38
+3% +$1.65K 0.03% 440
2025
Q1
$44.6K Hold
1,110
0.03% 476
2024
Q4
$50.9K Hold
1,110
0.03% 453
2024
Q3
$52K Hold
1,110
0.03% 446
2024
Q2
$46.9K Buy
+1,110
New +$48.7K 0.03% 450

Other funds holding QGEN

Cromwell Holdings's QGEN Position: Q2 2026 in Review

Cromwell Holdings increased its Qiagen (QGEN) stake by 86% in Q2 2026, buying an estimated $1.15K and bringing the position to 67 shares worth $2.62K. The position accounts for ﹤0.01% of the portfolio, ranked #794.

Cromwell Holdings first reported a position in QGEN in Q2 2024 and has held it in 9 quarters since. The position peaked at $55.2K in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Cromwell Holdings held 67 shares of Qiagen worth $2.62K as of Q2 2026.
  • Cromwell Holdings bought 31 Qiagen shares in Q2 2026, an estimated $1.15K.
  • Qiagen made up ﹤0.01% of Cromwell Holdings's portfolio in Q2 2026, its #794 holding.
  • Cromwell Holdings first reported a position in Qiagen in Q2 2024 and has held it in 9 quarters since.
  • Cromwell Holdings's Qiagen position peaked at $55.2K in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.